ANRO
Price
$2.30
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
63.62M
44 days until earnings call
NTLA
Price
$10.74
Change
+$0.01 (+0.09%)
Updated
Jul 3 closing price
Capitalization
1.11B
25 days until earnings call
Interact to see
Advertisement

ANRO vs NTLA

Header iconANRO vs NTLA Comparison
Open Charts ANRO vs NTLABanner chart's image
Alto Neuroscience
Price$2.30
Change-$0.00 (-0.00%)
Volume$967
Capitalization63.62M
Intellia Therapeutics
Price$10.74
Change+$0.01 (+0.09%)
Volume$2.81M
Capitalization1.11B
ANRO vs NTLA Comparison Chart in %
Loading...
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANRO vs. NTLA commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANRO is a Hold and NTLA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (ANRO: $2.35 vs. NTLA: $10.74)
Brand notoriety: ANRO and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANRO: 29% vs. NTLA: 58%
Market capitalization -- ANRO: $63.62M vs. NTLA: $1.11B
ANRO [@Biotechnology] is valued at $63.62M. NTLA’s [@Biotechnology] market capitalization is $1.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANRO’s FA Score shows that 1 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • ANRO’s FA Score: 1 green, 4 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, NTLA is a better buy in the long-term than ANRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANRO’s TA Score shows that 4 TA indicator(s) are bullish while NTLA’s TA Score has 5 bullish TA indicator(s).

  • ANRO’s TA Score: 4 bullish, 5 bearish.
  • NTLA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than ANRO.

Price Growth

ANRO (@Biotechnology) experienced а +2.17% price change this week, while NTLA (@Biotechnology) price change was +11.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ANRO is expected to report earnings on Aug 19, 2025.

NTLA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.11B) has a higher market cap than ANRO($63.6M). NTLA YTD gains are higher at: -7.890 vs. ANRO (-44.444). ANRO has higher annual earnings (EBITDA): -60.98M vs. NTLA (-530.8M). NTLA has more cash in the bank: 504M vs. ANRO (161M). ANRO has less debt than NTLA: ANRO (26.4M) vs NTLA (119M). NTLA has higher revenues than ANRO: NTLA (45.6M) vs ANRO (0).
ANRONTLAANRO / NTLA
Capitalization63.6M1.11B6%
EBITDA-60.98M-530.8M11%
Gain YTD-44.444-7.890563%
P/E RatioN/AN/A-
Revenue045.6M-
Total Cash161M504M32%
Total Debt26.4M119M22%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANRONTLA
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 20 days ago
90%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWHOX29.420.47
+1.62%
Nationwide Bailard Tech & Sci A
TRPGX15.620.16
+1.03%
Nuveen Core Equity Premier
DQIYX33.250.24
+0.73%
BNY Mellon Equity Income Fund Y
GQJIX11.440.06
+0.53%
GQG Partners Intl Qual Val Fd Ins
CSMAX14.700.05
+0.34%
Calvert Global Small-Cap Equity A

ANRO and

Correlation & Price change

A.I.dvisor tells us that ANRO and NUVL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANRO and NUVL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANRO
1D Price
Change %
ANRO100%
+2.17%
NUVL - ANRO
30%
Poorly correlated
-0.02%
XTLB - ANRO
26%
Poorly correlated
+10.00%
RLAY - ANRO
26%
Poorly correlated
N/A
NTLA - ANRO
26%
Poorly correlated
+0.09%
BEAM - ANRO
25%
Poorly correlated
+0.65%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+0.09%
VCYT - NTLA
69%
Closely correlated
N/A
CRSP - NTLA
66%
Closely correlated
+0.97%
BEAM - NTLA
65%
Loosely correlated
+0.65%
RXRX - NTLA
56%
Loosely correlated
+1.15%
ABCL - NTLA
55%
Loosely correlated
+1.33%
More